Below are the most recent publications written about "Follicle Stimulating Hormone" by people in Profiles.
-
Wenner MM, Shenouda N, Shoemaker L, Kuczmarski A, Haigh K, Del Vecchio A, Schwab A, McGinty SJ, Edwards DG, Pohlig RT, Nuckols VR, DuBose L, Moreau KL. Characterizing vascular and hormonal changes in women across the life span: a cross-sectional analysis. Am J Physiol Heart Circ Physiol. 2024 11 01; 327(5):H1286-H1295.
-
Pirtea P, de Ziegler D, Marin D, Sun L, Tao X, Ayoubi JM, Franasiak J, Scott RT. Gonadotropin receptor polymorphisms (FSHR N680S and LHCGR N312S) are not predictive of clinical outcome and live birth in assisted reproductive technology. Fertil Steril. 2022 09; 118(3):494-503.
-
Franasiak JM. Follicle-stimulating hormone dosage negatively associated with live birth in donor/recipient model: a case for milder donor stimulation? Fertil Steril. 2020 09; 114(3):498-499.
-
Monseur BC, Franasiak JM, Sun L, Scott RT, Kaser DJ. Double intrauterine insemination (IUI) of no benefit over single IUI among lesbian and single women seeking to conceive. J Assist Reprod Genet. 2019 Oct; 36(10):2095-2101.
-
Shore ND, Guerrero S, Sanahuja RM, Gamb?s G, Parente A. A New Sustained-release, 3-Month Leuprolide Acetate?Formulation Achieves and Maintains Castrate Concentrations of Testosterone in Patients With Prostate Cancer. Clin Ther. 2019 03; 41(3):412-425.
-
Crawford ED, Tombal B, Keane T, Boccardo F, Miller K, Shore N, Moul JW, Damber JE, Collette L, Persson BE. FSH suppression and tumour control in patients with prostate cancer during androgen deprivation with a GnRH agonist or antagonist. Scand J Urol. 2018 Oct - Dec; 52(5-6):349-357.
-
Morin SJ, Tao X, Marin D, Zhan Y, Landis J, Bedard J, Scott RT, Seli E. DNA methylation-based age prediction and telomere length in white blood cells and cumulus cells of infertile women with normal or poor response to ovarian stimulation. Aging (Albany NY). 2018 12 08; 10(12):3761-3773.
-
Zolton JR, Parikh TP, Hickstein DD, Holland SM, Hill MJ, DeCherney AH, Wolff EF. Oocyte cryopreservation for women with GATA2 deficiency. J Assist Reprod Genet. 2018 Jul; 35(7):1201-1207.
-
Crawford ED, Schally AV, Pinthus JH, Block NL, Rick FG, Garnick MB, Eckel RH, Keane TE, Shore ND, Dahdal DN, Beveridge TJR, Marshall DC. The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy. Urol Oncol. 2017 05; 35(5):183-191.
-
Werner MD, Forman EJ, Hong KH, Franasiak JM, Molinaro TA, Scott RT. Defining the "sweet spot" for administered luteinizing hormone-to-follicle-stimulating hormone gonadotropin ratios during ovarian stimulation to protect against a clinically significant late follicular increase in progesterone: an analysis of 10,280 first in?vitro fertilization cycles. Fertil Steril. 2014 Nov; 102(5):1312-7.